The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKD
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Inflammation significantly contributes to the progression of chronic kidney disease (CKD). Inflammasome-dependent cytokines, such as IL-1β and IL-18, play a role in CKD, but their regulation during renal injury is unknown. Here, we analyzed the processing of caspase-1, IL-1β, and IL-18 after unilateral ureteral obstruction (UUO) in mice, which suggested activation of the Nlrp3 inflammasome during renal injury. Compared with wild-type mice, Nlrp3(-/-) mice had less tubular injury, inflammation, and fibrosis after UUO, associated with a reduction in caspase-1 activation and maturation of IL-1β and IL-18; these data confirm that the Nlrp3 inflammasome upregulates these cytokines in the kidney during injury. Bone marrow chimeras revealed that Nlrp3 mediates the injurious/inflammatory processes in both hematopoietic and nonhematopoietic cellular compartments. In tissue from human renal biopsies, a wide variety of nondiabetic kidney diseases exhibited increased expression of NLRP3 mRNA, which correlated with renal function. Taken together, these results strongly support a role for NLRP3 in renal injury and identify the inflammasome as a possible therapeutic target in the treatment of patients with progressive CKD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Self-citationGout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Self-citationCryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Bauernfeind, F. G., Horvath, G., Stutz, A., Alnemri, E. S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B. G., Fitzgerald, K. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901363 · Cited by 2,959
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Self-citationInnate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Self-citationThe Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Self-citationAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Self-citationLiu, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000106015.29070.e7 · Cited by 1,055
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy
Chevalier, R. L., Forbes, M. S., & Thornhill, B. A. (2009) · Kidney International · doi:10.1038/ki.2009.86 · Cited by 1,029
Cited by
Items 101–200 of 603
Glycine Amidinotransferase (GATM), Renal Fanconi Syndrome, and Kidney Failure
Reichold, M., Klootwijk, E. D., Reinders, J., Otto, E. A., Milani, M., Broeker, C., Laing, C. M., Wiesner, J., Devi, S., Zhou, W., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017111179 · Cited by 102
Targeting the NLRP3 inflammasome to treat cardiovascular fibrosis
Pinar, A. A., Scott, T., Huuskes, B. M., Cáceres, F. T., Kemp‐Harper, B. K., & Samuel, C. S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107511 · Cited by 103
The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders
Menini, S., Iacobini, C., Vitale, M., & Pugliese, G. (2020) · Cells · doi:10.3390/cells9081812 · Cited by 106
Mosterd, C. M., Kanbay, M., van den Born, B. H., van Raalte, D. H., & Rampanelli, E. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101484 · Cited by 105
Li, Z., Chi, H., Zhu, W., Yang, G., Song, J., Mo, L., Zhang, Y., Deng, Y., Xu, F., Yang, J., et al. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03157-2 · Cited by 102
IL-1 Inhibition and Vascular Function in CKD
Nowak, K. L., Chonchol, M., Ikizler, T. A., Farmer‐Bailey, H., Salas, N., Chaudhry, R., Wang, W., Smits, G., Tengesdal, I. W., Dinarello, C. A., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016040453 · Cited by 103
“09 Never 40 (17) 43 (9) 38 (8) Current 10 (4) 19 (4) 0 (0) Former 50 (21) 38 (8) 62 (13) MDRD eGFR, ml/min per 1.”
Self-citationWang, S., Li, Y., Fan, J., Zhang, X., Luan, J., Bian, Q., Ding, T., Wang, Y., Wang, Z., Song, P., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.292 · Cited by 97
Self-citationRole of Inflammasomes in Kidney Diseases via Both Canonical and Non-canonical Pathways
Xiang, H., Zhu, F., Xu, Z., & Xiong, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00106 · Cited by 102
“Recently, many researchers have proved that interfering with the activation of inflammasome could regulate CKD, indicating that the inflammasome is involved in the CKD pathogenesis (Vilaysane et al., 2010).”
BackgroundRenal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics
Islamuddin, M., & Qin, X. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01996-3 · Cited by 104
“These fi ndings indicate the involvement of NLRP3 in various kidney disorders [49, 180].”
BackgroundInfluentialDoes inflammation affect outcomes in dialysis patients?
Nowak, K. L., & Chonchol, M. (2018) · Seminars in Dialysis · doi:10.1111/sdi.12686 · Cited by 95
“the main form of circulating IL-1 and is initially synthesized as a precursor (pro-IL-1b) that becomes activated in the setting of a macromolecular structure known as the inflammasome,(10,11) which is activated in CKD and perpetuates the inflammatory response.(12,13) IL-6 is a proinflammatory cytokine that promotes in…”
BackgroundInfluentialLv, Z., Wang, Y., Liu, Y.-J., Mao, Y.-F., Dong, W.-W., Ding, Z.-N., Meng, G.-X., Jiang, L., & Zhu, X.-Y. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002799 · Cited by 91
TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
Ye, Z., Lulu, C., Xiangchang, Z., Fang, Q., Binjie, Z., Chunyang, L., Rao, T., & Dongsheng, O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.929262 · Cited by 104
“Besides, activation of NLRP3 inflammasome and NF-κB signaling aggravate kidney disease (Vilaysane et al., 2010; Shahzad et al., 2015).”
BackgroundBoini, K. M., Xia, M., Abais, J. M., Li, G., Pitzer, A. L., Gehr, T. W. B., Zhang, Y., & Li, P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.033 · Cited by 98
“Recent studies demonstrated the role of NALP3 inflammasomes in chronic kidney diseases including hyperhomocysteinemia-induced glomerular injury, acute ischemia reperfusioninduced injury, unilateral ureteral obstruction and renal biopsies from patients with nondiabetic kidney diseases [25-26, 37-40].”
BackgroundGao, L., Wu, W., Dong, L., Ren, G., Li, H.-D., Yang, Q., Li, X., Xu, T., Li, Z., Wu, B., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00479 · Cited by 93
Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction
WEIGT, S. S., Palchevskiy, V., & Belperio, J. A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93537 · Cited by 96
“NLRP3 is known to be expressed by human renal epithelial cells and leukocytes (24).”
The role of uric acid in inflammasome-mediated kidney injury
Braga, T. T., Foresto‐Neto, O., & Câmara, N. O. S. (2020) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000619 · Cited by 102
“Moreover, studies published over the past few years have demonstrated a role for the NLRP3 activation in the development of kidney inflammation and the development of renal fibrosis [17,18].”
BackgroundCellular and molecular choreography of neutrophil recruitment to sites of sterile inflammation
McDonald, B., & Kubes, P. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0784-9 · Cited by 101
“Similarly, bone-marrow transplantation experiments have revealed that NLR-based danger sensing within non-hematopoeitic cells of the kidney (likely tubular epithelium) is critical for sterile nephritis following ureteric obstruction [ 57 ].”
BackgroundNam, S. A., Kim, W.-Y., Kim, J. W., Park, S. H., Kim, H. L., Lee, M.-S., Komatsu, M., Ha, H., Lim, J. H., Park, C. W., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1356-0 · Cited by 92
Nam, B. Y., Jhee, J. H., Park, J., Kim, S., Kim, G., Park, J. T., Yoo, T., Kang, S., Yu, J., & Han, S. H. (2022) · Cell Death and Disease · doi:10.1038/s41419-021-04480-3 · Cited by 94
“Notably, kidney intrinsic cells express components of the NLRP3 inflammasome pathway [38], and activation of this signaling can contribute to kidney injury [15, 29].”
BackgroundThe Interplay between Immune and Metabolic Pathways in Kidney Disease
Jiao, B., & Qu, L. (2023) · Cells · doi:10.3390/cells12121584 · Cited by 97
Knockdown of NLRP3 alleviates high glucose or TGFB1-induced EMT in human renal tubular cells
Song, S., Qiu, D., Luo, F., Wei, J., Wu, M. T., Wu, H., Du, C., Du, Y., Ren, Y., Chen, N., et al. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0069 · Cited by 95
Is the inflammasome a potential therapeutic target in renal disease?
Turner, C. M., Arulkumaran, N., Singer, M., Unwin, R. J., & Tam, F. W. K. (2014) · BMC Nephrology · doi:10.1186/1471-2369-15-21 · Cited by 96
“Vilaysane A [80] Non-diabetic acute and chronic kidney diseases Human NA NA PTEC”
BackgroundInfluentialZhu, X., Shi, J., & Li, H. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.045 · Cited by 91
Niu, X., Yao, Q., Li, W., Zang, L., Li, W., Zhao, J., Liu, F., & Zhi, W. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.01.062 · Cited by 90
Effect and Regulation of the NLRP3 Inflammasome During Renal Fibrosis
Zhang, H., & Wang, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00379 · Cited by 92
“…evidence strongly indicates that the expression levels of NLRP3 and caspase-1 are significantly elevated in the kidneys of CKD or fibrosis patients (Vilaysane et al., 2010; Ke et al., 2018), suggesting that the NLRP3 inflammasome may be activated and involved in the regulation of renal fibrosis.”
BackgroundYang, Y. X., Zhang, D., Liu, J.-H., Hu, L.-S., Xue, Q., Ding, X., & Kong, L. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.04.011 · Cited by 91
Guo, H., Bi, X., Zhou, P., Zhu, S., & Ding, W. Q. (2017) · Mediators of Inflammation · doi:10.1155/2017/8316560 · Cited by 90
Pyroptosis in diabetic nephropathy
Mamun, A. A., Mimi, A. A., Wu, Y., Zaeem, M., Aziz, M. A., Suchi, S. A., Alyafeai, E., Munir, F., & Xiao, J. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.09.003 · Cited by 90
Meng, X., Li, H.-D., Wu, W., Tang, P. M., Ren, G., Gao, L., Li, X., Yang, Y., Xu, T., Ma, T., et al. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.115 · Cited by 90
Zhuang, Y., Ding, G., Zhao, M., Bai, M., Yang, L., Ni, J., Wang, R., Jia, Z., Huang, S., & Zhang, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.578260 · Cited by 86
“In the literature, several reports have shown a detrimental role of NLRP3 in some nonproteinuric kidney injury models, such as unilateral ureteral obstruction (12) and ischemia/reperfusion injury (27, 28).”
BackgroundHua, K., Yang, S., Kao, T.-Y., Chang, J., Chen, H., Tsai, Y.-J., Chen, A., Yang, S., Chao, L. K., & Ka, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077794 · Cited by 87
“[47] demonstrated that renal inflammation in a mouse renal fibrosis model is associated with activation of the NLRP3 inflammasome and overproduction of IL-1b and IL-18, and that the NLRP3 inflammasome plays a role in a variety of human non diabetic kidney diseases and chronic kidney diseases.”
BackgroundPro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity
Domingo, I. K., Latif, A., & Bhavsar, A. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137227 · Cited by 86
Zhuang, Y., Yasinta, M., Hu, C., Zhao, M., Ding, G., Bai, M., Yang, L., Ni, J., Wang, R., Jia, Z., et al. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00203.2014 · Cited by 82
“The direct effects of proteinuria on epithelial cell phenotypic transition (23), cell apoptosis (12), tubulointerstitial inflammation (2), and subsequent fibrotic response (13) may serve as the major factors in the progression of chronic kidney diseases (CKDs).”
BackgroundTargeting the NLRP3 inflammasome to Reduce Diet-induced Metabolic Abnormalities in Mice
Chiazza, F., Couturier-Maillard, A., Benetti, E., Mastrocola, R., Nigro, D., Cutrin, J. C., Serpe, L., Aragno, M., Fantozzi, R., Ryffel, B., et al. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00104 · Cited by 80
RetractedGao, P., He, F.-F., Tang, H. R., Lei, C., Chen, S., Meng, X., Su, H., & Zhang, C. (2015) · Journal of Diabetes Research · doi:10.1155/2015/504761 · Cited by 87
“Discussion NALP3 inflammasome activation is involved in the pathological processes of various kidney diseases, including DN, as we and other groups reported [13, 27–32].”
NLRP3 inflammasome mediates contrast media-induced acute kidney injury by regulating cell apoptosis
Shen, J., Wang, L., Jiang, N., Mou, S., Zhang, M., Gu, L., Shao, X., Wang, Q., Qi, C., Li, S., et al. (2016) · Scientific Reports · doi:10.1038/srep34682 · Cited by 87
Self-citationLacroix‐Lamandé, S., d’Andon, M. F., Michel, E., Ratet, G., Philpott, D. J., Girardin, S. E., Boneca, I. G., Vandewalle, A., & Werts, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101987 · Cited by 85
“Recently, the NLRP3 inflammasome has been shown to promote renal inflammation and chronic kidney disease after experimental renal injury in mice (37).”
BackgroundLu, A., Li, H., Niu, J., Wu, S., Xue, G., Yao, X., Guo, Q., Wan, N., Abliz, P., Yang, G., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600659 · Cited by 88
Kapetanaki, S., Kumawat, A. K., Persson, K., & Demirel, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111864 · Cited by 81
“It has previously been shown that NLRP3 via an inflammasome-independent role mediates renal injury and contributes to the progression of chronic kidney disease [68,69].”
BackgroundmROS-TXNIP axis activates NLRP3 inflammasome to mediate renal injury during ischemic AKI
Wen, Y., Liu, Y., Tang, T., Pan, M.-M., Xu, S.-C., Ma, K., Lv, L., Liu, H., & Liu, B. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.02.015 · Cited by 87
Gao, P., Meng, X., Su, H., He, F.-F., Chen, S., Tang, H. R., Tian, X., Fan, D., Wang, Y., Liu, J.-S., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.07.001 · Cited by 80
“Recently, the NALP3 inflammasome was identified as a possible therapeutic target in patients with progressive CKD [20].”
BackgroundNLRP3 inflammasome: Pathogenic role and potential therapeutic target for IgA nephropathy
Tsai, Y., Hua, K., Chen, A., Wei, C.-W., Chen, W., Wu, C.-Y., Chu, C., Yu, Y., Lo, C., & Ka, S. (2017) · Scientific Reports · doi:10.1038/srep41123 · Cited by 84
Involvement of Inflammasome Components in Kidney Disease
Aranda‐Rivera, A. K., Srivastava, A., Cruz‐Gregorio, A., Pedraza‐Chaverrí, J., Mulay, S. R., & Scholze, A. (2022) · Antioxidants · doi:10.3390/antiox11020246 · Cited by 79
A Tissue-Specific Role for Nlrp3 in Tubular Epithelial Repair after Renal Ischemia/Reperfusion
Bakker, P. J., Butter, L. M., Claessen, N., Teske, G. J. D., Sutterwala, F. S., Florquin, S., & Leemans, J. C. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.04.005 · Cited by 80
“This observation is consistent with articles demonstrating that Nlrp3 enhances renal epithelial-mesenchymal transition(27) and fibrosis in a model of unilateral ureteral obstruction.(19) In addition, mice that lack Nlrp3 in renal cells show increased levels of KC and MCP-1, suggesting a prolonged inflammatory phase th…”
BackgroundResultZhang, B., Zeng, M., Li, M., Kan, Y., Li, B., Xu, R., Wu, Y., Wang, S., Zheng, X., & Feng, W. (2019) · Molecules · doi:10.3390/molecules25010015 · Cited by 77
Kidney Aging and Chronic Kidney Disease
Zhang, Y., Chen, Y., & Li, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126585 · Cited by 86
“Additionally, it also revealed an upregulation in the expression of the NLRP3 inflammasome within the renal tubules of patients with diabetic and IgA-associated tubulointerstitial injuries [108].”
BackgroundZhao, M., Bai, M., Ding, G., Zhang, Y., Huang, S., Jia, Z., & Zhang, A. (2018) · Kidney Diseases · doi:10.1159/000488242 · Cited by 74
Role of mitochondria in pathogenesis and therapy of renal fibrosis
Zhao, X., Li, Y., Yu, J., Teng, H., Wu, S., Wang, Y., Zhou, H., & Li, F. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155913 · Cited by 76
Self-citationWu, X., Chang, S. C., Jin, J., Gu, W., & Li, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26784 · Cited by 75
“Studies on humans demonstrated increased NLRP3 in a variety of diabetic kidney diseases and CKD (Lee et al., 2013; Vilaysane et al., 2010).”
BackgroundInfluentialKadoya, H., Satoh, M., Sasaki, T., Taniguchi, S., Takahashi, M., & Kashihara, N. (2015) · The FASEB Journal · doi:10.1096/fj.15-271734 · Cited by 74
“Kidney and cell lysates were prepared as described previously (18, 25).”
MethodPyroptosis: A New Frontier in Kidney Diseases
Zhang, K., Wu, Q., Jiang, S., Ding, L., Liu, C.-X., Xu, M. Y., Wang, Y., Zhou, Y., & Li, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6686617 · Cited by 76
“Increased expression of NLRP3 and caspase-1, as well as enhanced release of the IL-1β and IL-18 inflammatory bodies, was observed in both renal biopsy specimens of UUO mice and humans with UUO (unilateral ureteral occlusion), whereas the degree of renal fibrosis was markedly alleviated in NLRP3 mice [72, 73].”
BackgroundThe Role of NLRP3 Inflammasome Activities in Bone Diseases and Vascular Calcification
Yu, C., Zhang, C., Kuang, Z., & Zheng, Q. (2020) · Inflammation · doi:10.1007/s10753-020-01357-z · Cited by 72
“disease (CKD)in human are substantially upregulated [111].”
Lichtnekert, J., Kulkarni, O. P., Mulay, S. R., Rupanagudi, K. V., Ryu, M., Allam, R., Vielhauer, V., Muruve, D. A., Lindenmeyer, M. T., Cohen, C. D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026778 · Cited by 78
“induced tubulointerstitial inflammation by UUO in Nlrp3-deficient mice and found less tubular damage and interstitial fibrosis as compared to wildtype mice [23].”
BackgroundSelf-citationSecondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage
Scarpioni, R., Ricardi, M., & Albertazzi, V. (2016) · World Journal of Nephrology · doi:10.5527/wjn.v5.i1.66 · Cited by 77
Wong, D. W. L., Yiu, W. H., Chan, K. W., Li, Y., Ли, Б., Lok, S. W. Y., Taketo, M. M., Igarashi, P., Chan, L. Y. Y., Leung, J. C. K., et al. (2018) · Kidney International · doi:10.1016/j.kint.2017.12.017 · Cited by 74
Self-citationPyroptosis: Mechanisms and Links with Fibrosis
Song, Z., Gong, Q., & Guo, J. (2021) · Cells · doi:10.3390/cells10123509 · Cited by 74
“Komada et al. [76] found that both AIM2 and NLRP3 knockout effectively reduced renal collagen deposition and the fibrosis area 7 days after the establishment of a mouse UUO model.”
BackgroundChun, J., Chung, H., Wang, X., Barry, R., Taheri, Z. M., Platnich, J. M., Ahmed, S. B., Trpkov, K., Hemmelgarn, B. R., Benediktsson, H., et al. (2016) · Scientific Reports · doi:10.1038/srep24667 · Cited by 73
Self-citationWang, J., Wen, Y., Lv, L., Liu, H., Tang, R., Ma, K., & Liu, B. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.21 · Cited by 69
Gong, C., Zunfeng, L., Chengwei, Q., Bu, X., & Yu, J. (2016) · Oncotarget · doi:10.18632/oncotarget.13010 · Cited by 69
Komada, T., Usui, F., Shirasuna, K., Kawashima, A., Kimura, H. J., Karasawa, T., Nishimura, S., Sagara, J., Noda, T., Taniguchi, S., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.01.014 · Cited by 67
Thomas, J., Huuskes, B. M., Sobey, C. G., Drummond, G. R., & Vinh, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108191 · Cited by 67
Foresto‐Neto, O., Menezes-Silva, L., Leite, J. A., Andrade-Silva, M., & Câmara, N. O. S. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090122-045843 · Cited by 75
NLRP3 Inflammasome: A central player in renal pathologies and nephropathy
Henedak, N. T., El-Abhar, H. S., Soubh, A. A., & Abdallah, D. M. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122813 · Cited by 69
Wen, Y., Liu, Y., Tang, T., Lv, L., Liu, H., Ma, K., & Liu, B. (2016) · Oncotarget · doi:10.18632/oncotarget.11091 · Cited by 69
“also demonstrated that NLRP3 inflammasome was involved in unilateral ureteral obstruction (UUO)-induced renal inflammation and contributed to the progression of chronic kidney disease [12].”
BackgroundTang, P., Zhu, R., Ji, W., Wang, J., Chen, S., Fan, S.-W., & Hu, Z. (2016) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-016-4866-4 · Cited by 65
“Previous research indicated that dysfunction of the NLRP3 inflammasome and its final breakdown product IL-1b plays a vital role in the pathogenesis of diseases such as chronic kidney disease [46], gastric tumors [41], fibromyalgia [9], and coronary artery disease [38].”
BackgroundRoughley, M., Sultan, A. A., Clarson, L. E., Müller, S., Whittle, R., Belcher, J., Mallen, C. D., & Roddy, E. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-018-1746-1 · Cited by 69
Chen, L., Hou, X., Zhang, M., Zheng, Y., Zheng, X., Yang, Q., Li, J., Gu, N., Zhang, M., Sun, Y., et al. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2019.10.027 · Cited by 61
Ram, C., Jha, A. K., Ghosh, A., Gairola, S., Syed, A. M., Murty, U. S., Naidu, V. G. M., & Sahu, B. D. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173503 · Cited by 65
Xie, Y., Hu, X.-F., Li, S., Qiu, Y., Cao, R., Xu, C., Lu, C., Wang, Z., & Yang, J. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106161 · Cited by 64
NLRP3 inflammasome inhibition ameliorates tubulointerstitial injury in the remnant kidney model
Foresto‐Neto, O., Ávila, V. F., Arias, S. C. A., Zambom, F. F. F., Rempel, L. C. T., Faustino, V. D., Machado, F. G., Malheiros, D. M. A. C., Abensur, H., Câmara, N. O. S., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0029-4 · Cited by 63
Yin, F., Zheng, P., Zhao, L., Wang, Y., Miao, N., Zhou, Z., Cheng, Q., Chen, P., Xie, H., Li, J., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00619-2 · Cited by 67
Liu, Z., Wang, X., Wang, Y., & Zhao, M. (2017) · Immunologic Research · doi:10.1007/s12026-017-8901-7 · Cited by 68
“Emerging evidence suggested that NLRP3 inflammasome was involved in the induction of renal inflammation [29], ischemia/reperfusion [30], and fibrosis [31]; however, its role on acute kidney injury induced by PQ is unknown.”
BackgroundNLRP2 Regulates Proinflammatory and Antiapoptotic Responses in Proximal Tubular Epithelial Cells
Rossi, M. N., Pascarella, A., Licursi, V., Caiello, I., Taranta, A., Rega, L. R., Levtchenko, E. N., Emma, F., Benedetti, F. D., & Prencipe, G. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00252 · Cited by 65
“Consistently, the absence of specific inflammasome components in murine models of acute or chronic kidney diseases has been demonstrated to protect mice from kidney failure (Shigeoka et al., 2010; Vilaysane et al., 2010; Zhuang et al., 2015).”
BackgroundNLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity
Wei, S., Ma, W., Zhang, B., & Li, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.634607 · Cited by 61
“Many kidney diseases exhibited increased expression of NLRP3 mRNA in kidney tissue from human renal biopsies, and the NLRP3 mRNA level was correlated with renal function (Vilaysane et al., 2010).”
BackgroundBronchial asthma is associated with increased risk of chronic kidney disease
Huang, H. L., Ho, S., Li, C.-H., Chu, F.-Y., Ciou, L.-P., Lee, H. C., Chen, W., & Tzeng, N. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-80 · Cited by 63
“The NLRP3 inflammasome contributes to the progression of CKD by promoting renal inflammation [35] and plays a role in the human rhinovirus-related primary bronchial cell inflammation [36].”
BackgroundLin, Y., Lee, Y., Hsu, Y., Chen, Y.-J., Lin, Y., Cheng, F., & Chiu, H. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0256 · Cited by 62
Li, W., He, W., Xia, P., Sun, W., Shi, M., Zhou, Y., Zhu, W., Zhang, L., Liu, B.-H., Zhu, J., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00567 · Cited by 63
“Accumulating data suggests that the inflammasome is activated in patients with CKD as well as in animal models of this condition (Martinon and Tschopp, 2007; Vilaysane et al., 2010; Anders and Muruve, 2011; Zhuang et al., 2014).”
BackgroundBenigni, A., Perico, L., & Macconi, D. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6682 · Cited by 62
Yeh, W.-J., Yang, H., Pai, M., Wu, C., & Chen, J. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.09.014 · Cited by 60
Host Response to Leptospira Infection
Zuerner, R. L. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-45059-8_9 · Cited by 58
The NLRP3 Inflammasome Suppresses Protective Immunity to Gastrointestinal Helminth Infection
Al-Hallaf, R., Agha, Z., Miller, C., Robertson, A. A. B., Sotillo, J., Croese, J., Cooper, M. A., Masters, S. L., Kupz, A., Smith, N. C., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.097 · Cited by 59
Pyroptosis and Redox Balance in Kidney Diseases
Cuevas, S., & Pelegrín, P. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8243 · Cited by 59
“IL-1 b concentration in renal tissue homogenates is increased in animal models with unilateral ureter obstruction (UUO) (177), and the urine concentration of IL-18 is increased in urine in both animal models and patients with nephropathy (116, 120).”
Pulskens, W. P. C., Butter, L. M., Teske, G. J. D., Claessen, N., Dessing, M. C., Flavell, R. A., Sutterwala, F. S., Florquin, S., & Leemans, J. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085775 · Cited by 56
“found that renal injury is particularly reflected by high levels of cortical tubular necrosis (up to 80%) [10].”
BackgroundResultInfluentialRole of the nucleotide‐binding domain‐like receptor protein 3 inflammasome in acute kidney injury
Cao, Y., Fei, D., Chen, M., Sun, M., Xu, J., Kang, K., Jiang, L., & Zhao, M. (2015) · FEBS Journal · doi:10.1111/febs.13379 · Cited by 58
Bugyei‐Twum, A., Abadeh, A., Thai, K., Zhang, Y., Mitchell, M., Kabir, G., & Connelly, K. A. (2016) · Scientific Reports · doi:10.1038/srep39551 · Cited by 56
NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury
Bai, M., Chen, Y., Zhao, M., Zhang, Y., He, J. C., Huang, S., Jia, Z., & Zhang, A. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00332.2016 · Cited by 56
“290 NLRP3 inflammasome has been shown the deleterious roles in both renal tubular 291 injuries and glomerular diseases (7, 16, 24).”
BackgroundThe NLPR3 inflammasome and obesity‐related kidney disease
Ke, B., Shen, W., Fang, X., & Wu, Q. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13333 · Cited by 55
“On one hand, NLRP3 activation in TECs was shown to drive the EMT during progressive renal fibrosis [48], as Nlrp3 / mice displayed reduced tubular injury and interstitial fibrosis upon unilateral ureteral ligation compared with wild-type animals [48].”
BackgroundCaspase-11 promotes renal fibrosis by stimulating IL-1β maturation via activating caspase-1
Miao, N., Xie, H., Xu, D., Yin, J., Wang, Y., Bao, W., Yin, F., Zhou, Z., Cheng, Q., Chen, P., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0177-5 · Cited by 56
Research Progress on the Role of Inflammasomes in Kidney Disease
Chi, K., Geng, X., Liu, C., Cai, G., & Hong, Q. (2020) · Mediators of Inflammation · doi:10.1155/2020/8032797 · Cited by 55
“The expression of NLRP3 mRNA in renal biopsy specimens of patients with hypertensive or vascular nephrosclerosis is higher than that in normal kidneys, suggesting that NLRP3 plays a role in hypertension-related kidney disease [57].”
BackgroundFetuin-A is a HIF target that safeguards tissue integrity during hypoxic stress
Rudloff, S., Janot, M., Rodriguez, S., Dessalle, K., Jahnen‐Dechent, W., & Huynh‐Do, U. (2021) · Nature Communications · doi:10.1038/s41467-020-20832-7 · Cited by 62
Dong, W., Zhang, K., Wang, X., Li, J., Zou, H., Yuan, Y., Gu, J., Zhu, J., Liu, G., Liu, Z., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.172392 · Cited by 54
Luo, Y., Long, M., Wu, X., & Zeng, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1703560 · Cited by 58
“In fl ammatory responses signi fi cantly promote the progression of CKD by activating the NLRP3 – ASC – caspase-1 axis to induce and release in fl ammatory cytokines like IL-1 b and IL-18, which play pivotal roles in the onset and advancement of CKD (16).”
InfluentialIcariin ameliorates IgA nephropathy by inhibition of nuclear factor kappa b/Nlrp3 pathway
Zhang, L., Wang, X., Li, Y., Zhang, L., & Hao, L. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12161 · Cited by 54
Self-citationSingh, J. A., & Cleveland, J. D. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1274-5 · Cited by 54
Deplano, S., Cook, H. T., Russell, R. F., Franchi, L., Schneiter, S., Bhangal, G., Unwin, R. J., Pusey, C. D., Tam, F. W. K., & Behmoaras, J. V. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0612284 · Cited by 56
“Although there are reports implicating inflammasomes in chronic [39] kidney disease, there is no report showing the role of inflammasomes in macrophage-dependent Crgn.”
BackgroundWang, M.-Y., Zhang, Z., Zhao, S., Onodera, T., Sun, X.-N., Zhu, Q., Li, C., Li, N., Chen, S., Paredes, M., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.024 · Cited by 52
Yu, G., Bai, Z., Chen, Z., Chen, H., Wang, G., Wang, G., & Liu, Z. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.12.022 · Cited by 53
Sogawa, Y., Nagasu, H., Iwase, S., Ihoriya, C., Itano, S., Uchida, A., Kidokoro, K., Taniguchi, S., Takahashi, M., Satoh, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08054-2 · Cited by 56
Roles of Inflammasomes in Inflammatory Kidney Diseases
Fan, J., Xie, K., Wang, L., Zheng, N., & Yu, X. (2019) · Mediators of Inflammation · doi:10.1155/2019/2923072 · Cited by 53
“However, increased NLRP3 expression was associated with better clinical outcome in IgAN, for reasons still unclear [69, 82].”
BackgroundWang, W., Luo, R., Lin, Y., Wang, F., Zheng, P., Levi, M., Yang, T., & Li, C. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00649.2014 · Cited by 51
“Activation of NLRP3-ASC-caspase-1-IL-1β axis has 112 been demonstrated to play a substantial role in renal injury and fibrosis induced by UUO 113 (47).”
BackgroundSelf-citation
Metadata
- Authors
- Vilaysane, A., Chun, J., Seamone, M. E., Wang, W., Chin, R., Hirota, S., Li, Y., Clark, S. A., Tschopp, J., Trpkov, K., Hemmelgarn, B. R., Beck, P. L., & Muruve, D. A.
- Affiliations
- University of Calgary (CA)
- Corresponding author
- Vilaysane, Akosua
- Chun, Justin
- Seamone, Mark E.
- Wang, Wenjie
- Chin, Rick
- Hirota, Simon
- Li, Yan
- Clark, Sharon A.
- Hemmelgarn, Brenda R.
- Beck, Paul L.
- Muruve, Daniel A.
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2010-10
- Volume
- 21
- Issue
- 10
- Pages
- 1732-1744
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC3013544
- OpenAlex
- W2111994713
- Cited by
- 587
- References
- 44
- Citations by year
- 2026: 30 · 2025: 44 · 2024: 48 · 2023: 40 · 2022: 50 · 2021: 42 · 2020: 43 · 2019: 42 · 2018: 46 · 2017: 36 · 2016: 44 · 2015: 29 · 2014: 36 · 2013: 26 · 2012: 16
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- NLRP3 inflammasome, chronic kidney disease, renal inflammation, caspase-1, IL-1β, IL-18, unilateral ureteral obstruction, renal tubular injury, renal fibrosis, non-diabetic kidney disease, therapeutic target
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Cells, Cultured, Fibrosis, Humans, Kidney, Male, Mice, Inbred C57BL, Nephritis, RNA, Messenger, Ureteral Obstruction, Mice, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.